Global MET Inhibitors for Lung Cancer Market to Reach USD 2.5...

added blog Other

2026-03-13 09:16:09

Global MET Inhibitors for Lung Cancer Market to Reach USD 2.5 Billion by 2032 at 8.5% CAGR

According to a newly published market research report by 24LifeSciences, the global MET inhibitors for lung cancer market was valued at USD 1.1 billion in 2024 and is projected to reach USD 2.5 billion by 2032, growing at a compound annual growth rate (CAGR) of 8.5% during the forecast period 20252032. MET inhibitors represent a breakthrough class of targeted cancer therapies...

0 Comments 0 Shares 10 Views 0 Reviews